Publisher Correction: Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS).


Journal

Bone marrow transplantation
ISSN: 1476-5365
Titre abrégé: Bone Marrow Transplant
Pays: England
ID NLM: 8702459

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 2 4 2019
medline: 2 4 2019
entrez: 2 4 2019
Statut: ppublish

Résumé

The original version of this article included some minor typesetting errors in Table 1-a corrected version of which is provided in this correction article and has been corrected in the original article-and one error in text, which has been corrected in the original article. Furthermore, the article was erroneously published with the copyright holders as 'Springer Nature Limited', however, since the article is Open Access, the copyright holders should in fact be 'The Author(s)'. This has also been corrected in the original article.

Identifiants

pubmed: 30932018
doi: 10.1038/s41409-019-0507-3
pii: 10.1038/s41409-019-0507-3
pmc: PMC7608333
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

2117-2119

Commentaires et corrections

Type : ErratumFor

Références

Biol Blood Marrow Transplant. 2016 Jul;22(7):1306-1312
pubmed: 27108694
Transplant Proc. 2007 Jun;39(5):1558-63
pubmed: 17580188
Blood. 2002 Dec 15;100(13):4337-43
pubmed: 12393437
Biol Blood Marrow Transplant. 2010 Jul;16(7):1005-17
pubmed: 20167278
Eur J Hosp Pharm. 2019 Nov;26(6):343-346
pubmed: 31798859
Bone Marrow Transplant. 2004 Jan;33(2):189-95
pubmed: 14661036
Biol Blood Marrow Transplant. 2016 Oct;22(10):1874-1882
pubmed: 27397724
Biol Blood Marrow Transplant. 2015 Dec;21(12):2148-2153
pubmed: 26278046
Blood. 1998 Aug 1;92(3):737-44
pubmed: 9680339
Br J Haematol. 2000 Dec;111(4):1122-9
pubmed: 11167751
Pediatr Blood Cancer. 2007 Jun 15;48(7):700-4
pubmed: 16786586
Bone Marrow Transplant. 2016 Sep;51(9):1262-4
pubmed: 27111044
Blood. 2016 Mar 31;127(13):1656-65
pubmed: 26825712

Auteurs

Paul Richardson (P)

Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Saurabh Aggarwal (S)

Novel Health Strategies, Bethesda, MD, USA. sa2@novelhealthstrategies.com.

Ozlem Topaloglu (O)

Novel Health Strategies, Bethesda, MD, USA.

Kathleen F Villa (KF)

Jazz Pharmaceuticals, Inc, Palo Alto, CA, USA.

Selim Corbacioglu (S)

Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany.

Classifications MeSH